SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-056981
Filing Date
2022-05-06
Accepted
2022-05-06 16:06:28
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 tm2213686-1_s3.htm S-3 382059
2 EXHIBIT 4.3 tm2213686d2_ex4-3.htm EX-4.3 364533
3 EXHIBIT 5.1 tm2213686d2_ex5-1.htm EX-5.1 18634
4 EXHIBIT 5.2 tm2213686d2_ex5-2.htm EX-5.2 26447
5 EXHIBIT 23.3 tm2213686d2_ex23-3.htm EX-23.3 2190
6 EX-FILING FEES tm2213686d2_ex-fillingfees.htm EX-FILING FEES 34529
7 GRAPHIC tm2213686d2_ex5-1img01.jpg GRAPHIC 5070
8 GRAPHIC tm2213686d2_ex5-2img01.jpg GRAPHIC 4210
9 GRAPHIC tm2213686d2_ex5-2img02.jpg GRAPHIC 3510
10 GRAPHIC lg_kiniksa-4c.jpg GRAPHIC 93357
  Complete submission text file 0001104659-22-056981.txt   976201
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264746 | Film No.: 22901046
SIC: 2834 Pharmaceutical Preparations